CXCL9 and neoplasm: In order to test the functional significance of the increased expression of CXCL9 and CXCL10 from the tumor cells treated with GSK126 and IFNγ, we performed a transwell migration assay using conditioned medium from U251 cells (since they responded to GSK126 treatment) and T cells isolated from five healthy donor PBMCs.